Information About Successful Completion Of Inspection Of JSTL Clinical And Bioanalytical Facilities By CDSCO (Central Drugs Standard Control Organisation) Under Regulation 30 Of SEBI (LODR) Regulations 2015.

Information about successful completion of Inspection of JSTL Clinical and Bioanalytical facilities by CDSCO (Central Drugs Standard Control Organisation) under Regulation 30 of SEBI(LODR) Regulations 2015.

Shareholder Meeting / Postal Ballot-Outcome of EGM

Outcome of the EGM held on 27.03.2025

Shareholder Meeting / Postal Ballot-Scrutinizers Report

Scrutiniser report of the EGM held on 27.03.2025

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jeevan Krishna Kuchipudi

Closure of Trading Window

Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations 2015

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jeevan Krishna Kuchipudi

Announcement under Regulation 30 (LODR)-Newspaper Publication

Copy of Newspaper Cuttings of the Standalone and Consolidated Unaudited Financial Results for the Quarter Ended 30th June2024.

Shareholder Meeting / Postal Ballot-Outcome of AGM

Outcome of 26th Annual General Meeting held on 09.08.2024

Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended 30.06.2024 Under Regulation

Outcome of Board Meeting for the quarter ended 30.06.2024 under regulation 30 and 33 of SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.

Shareholder Meeting / Postal Ballot-Scrutinizers Report

Disclosure under Regulation 44(3) of SEBI (LODR) Regulations 2015

Unaudited Financial Results For The Quarter Ended 30.06.2024

Unaudited Financial Results for the quarter ended 30.06.2024

Board Meeting Intimation for The Meeting To Be Held On 09.08.2024

Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve 1. Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2024. 2.... More> y other business with the permission of the Chair.<Less

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Compliance as per Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2024.

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement- Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ( SEBI Listing Regulations).

Shareholders Meeting-AGM- Friday 09Th August 2024 At 10:00 AM.

Annual General Meeting of the Company is scheduled to be held on Friday 09th August 2024 at 10:00 a.m. through video conference / other audio-visual means.

Reg. 34 (1) Annual Report.

26th Annual Report for the FY 2023-24

Intimation Of Book Closure And Cut-Off Date For The 26Th Annual General Meeting Of Jeevan Scientific

Intimation of Book Closure and Cut-Off Date for the 26th Annual General Meeting of Jeevan Scientific Technology Limited.

Closure of Trading Window

The trading window for dealing in the securities of the Company will remain close from 01.07.2024 till 48 hours after the declaration of Financial Results for the quarter ended 30.06.2024 for all designated persons their immediate relatives and all connected persons... More> vered under the Companys Code of Conduct.<Less

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of issue of Duplicate Share Certificates under Regulation 39(3) of SEBI (LODR) Regulations 2015

Receipt Of Bioequivalence Center Approval From Sultanate Of Oman Ministry Of Health Drug Safety Cent

Receipt of Bioequivalence center approval from sultanate of Oman Ministry of Health Drug safety center Oman

Announcement under Regulation 30 (LODR)-Newspaper Publication

Copy of Newspaper cuttings of the standalone and consolidated Audited financial results for the quarter and year ended 31.03.2024

Board Meeting Outcome for Outcome Of Board Meeting For The Quarter And Year Ended 31.03.2024 Under R

Outcome of Board Meeting for the quarter and year ended 31.03.2024 under regulation 30 and 33 of SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.

Announcement under Regulation 30 (LODR)-Change in Management

Announcement under Regulation 30 of SEBI (LODR) Regulations 2015

Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended 31.

Audited financial results ( Standalone and Consolidated) for the quarter and financial year ended 31.03.2024

Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Compliance Report for the year ended March 31 2024

Board Meeting Intimation for The Meeting To Be Held On 30.05.2024

Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve 1. Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended... More> 024. 2. Audit Report (Standalone and Consolidated) for the year ended 31.03.2024. 3. Any other business with the permission of the Chair.<Less

Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Jeevan Scientific Technology Ltd 2 CIN NO. ... More> 31016 3 Report filed for FY 2023-2024 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2023-24 2024-25 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d) which has been met from (c)(e)* 0 9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0 Details of penalty to be paid if any in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2023-24 2022-23 Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Sharvari Swapnil ShindeDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Jeevan Krishna Kuchipudi Designation : -Executive Director and Chief Financial Officer Date: 19/04/2024<Less

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyJeevan Scientific Technology Ltd 2CIN NO.L72200TG1999PLC031016 3 Outstanding borrowing of company as on 31st March / 31st December as... More> licable (in Rs cr) 4.10 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: Sharvari Swapnil Shinde Designation: Company Secretary and Compliance Officer EmailId: info?jeevanscientific.com Name of the Chief Financial Officer: Jeevan Krishna Kuchipudi Designation: Executive Director and Chief Financial Officer EmailId: jeevan.kuchipudi?jeevanscientific.com Date: 19/04/2024 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. <Less

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Compliance certificate under Reg 74(5) of SEBI (DP) Regulations 2018

Compliance Certificate For The Period Ended 31.03.2024

Disclosure under Regulation 7(3) of SEBI (LODR) Regulations 2015

Compliance As Per Regulation 40 (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regul

Compliance as per Regulation 40(10) of SEBI (LODR) Regulations 2015 for the year ended 31.03.2024

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Krishna Kishore Kuchipudi

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Krishna Kishore Kuchipudi

Closure of Trading Window

Closure of Trading window

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Krishna Kishore Kuchipudi

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Krishna Kishore Kuchipudi

Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

Resignation of Company Secretary and Compliance Officer

Information About The Successful Completion Of USFDA Inspection At JSTL Under Regulation 30 Of SEBI

Information about the successful completion of USFDA inspection at JSTL under Regulation 30 of SEBI (LODR) Regulations 2015

Announcement under Regulation 30 (LODR)-Newspaper Publication

Copy of newspaper cuttings of the standalone and consolidated unaudited financial results for the quarter and nine months ended 31.12.2023

Un Audited Financial Results ( Standalone And Consolidated) For The Quarter Ended 31.12.2023

Un Audited Financial Results ( Standalone and Consolidated) for the quarter ended 31.12.2023

Board Meeting Outcome for Outcome Of Board Meeting For The Quarter And Nine Months Ended 31.12.2023

With reference to the subject cited this is to inform the exchange that the Board of Directors of Jeevan Scientific Technology Limited at its meeting held on Wednesday the 14th day of February 2024 at 04:30 P.M. at registered office of the Company for the quarter and... More> ine months ended 31.12.2023 considered and approved the following: 1. Un- Audited Financial Results (standalone and consolidated) for the quarter and nine months ended 31.12.2023. (Attached) 2. Limited Review Report (standalone and consolidated) for the Quarter and nine months ended 31.12.2023. (Attached)<Less

Board Meeting Intimation for The Meeting To Be Held On 14.02.2024.

Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. Unaudited Financial results (Standalone and Consolidated) for the quarter and nine months ended... More> 1.12.2023. 2. Any other business with the permission of the Chair.<Less

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Compliance as per Regulation 74(5) of the SEBI ( Depositories and Participants) Regulations 2018 for the quarter ended December 31 2023